Evaluate Bioequivalence of Micafungin (50mg/Vial)

Clinical trial NCT05496725 · COMPLETED

Trial details

NCT number: NCT05496725
Sponsor: Yung Shin Pharm. Ind. Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Invasive Candidiasis

Start date: 2022-01-06
Primary completion: 2022-05-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.